STUDY ABOUT ANTI-DEMENTIA DRUG USE IN PRIMARY CARE

被引:0
|
作者
Carracedo Martinez, Eduardo [1 ]
机构
[1] SERGAS, Area Sanit Santiago de Compostela, Santiago De Compostela, A Coruna, Spain
来源
ATENCION FARMACEUTICA | 2009年 / 11卷 / 02期
关键词
MEMANTINE; CHOLINESTERASE INHIBITORS; ALZHEIMER'S; PRIMARY CARE; ALZHEIMERS-DISEASE; MEMANTINE TREATMENT; CONTROLLED-TRIAL; DEMENTIA; MODERATE; PREVALENCE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To perform a study about the use of memantine and cholinesterase inhibitors (donepezil, galantamine and rivastigmine) in primary care. Method: Cross-sectional 3-month study in five primary care units from the Santiago de Compostela (A Coruna) Healthcare Area. Results: The prevalence in the use of anti-dementia drugs is 0.36% with a 95% confidence interval (CI 95%) of 0.27% to 0.45%. No active principle is more used than the others. 96% of patients suffer from Alzheimer and 4% of Parkinson's-related dementia. 25% of these patients use memantine together with a cholinesterase inhibitor Conclusions: There is a widespread use of anti-dementia drugs even if the cognitive benefits are not yet considered as of clinical relevance. As well, the proportion of patients that use together these two anti-dementia drugs is high even if the efficacy of such association is under question.
引用
收藏
页码:124 / 126
页数:3
相关论文
empty
未找到相关数据